Document Type : Original Article


1 Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Federal University, Oye–Ekiti, Ekiti State, Nigeria

2 Department of pharmacology, Faculty of pharmacy, Lead City University, Ibadan, Nigeria

3 Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Gombe State University, Gombe State, Nigeria



Background and Objective: COVID-19 has had a worldwide impact in a variety of ways since its discovery in China. As a result, it's critical to maintain a constant eye on the virus's impact around the world. The goal of this research is to compile a global assessment of COVID-19 demographics and distribution, as well as a COVID-19 update report till February 17th, 2022.
Methods: Data was provided by the United Nations Geochem database from 151 nations and areas throughout the world. The results were compiled and compared to the figures obtained for the United States.
Result: When compared to the United States, the American continent has a lower incidence but the same fatality rate. When compared to the United States, most European and Asian countries have the same cumulative incidence and mortality rates as the United States, except for a few countries such as the United Kingdom and the Netherlands. When compared to the United States, the African continent has an extremely low incidence and fatality rate.
Conclusion: The development of the Omicron variety seems to make COVID-19's approach and comprehension more complicated. As a result, the virus has had a long-term impact all over the world. Africa, on the other hand, is not particularly afflicted by all the virus's strains. As a result, the rest of the world must research the cause of this "African exception" and maybe comprehend its ramifications in terms of potential immunity.


Main Subjects